Skip to main content

Table 1 Patient Characteristics

From: Decompressive craniectomy combined with mild hypothermia in patients with large hemispheric infarction: a randomized controlled trial

Variables

DC (n = 9)

DCSC (n = 14)

DCEH (n = 11)

P value

Age, years, mean ± SD

63.22 ± 8.66

56.07 ± 11.23

58.18 ± 9.92

0.298

Male, n (%)

8 (88.9)

11 (78.6)

9 (81.8)

0.817

Comorbidity, n (%)

 Hypertension

4 (44.4)

4 (28.6)

3 (27.3)

0.663

 Coronary heart disease

0

0

0

 

 Valvular dysfunction

1 (11.1)

2 (14.3)

2 (18.2)

0.905

 Atrial fibrillation

4 (44.4)

5 (35.7)

3 (27.3)

0.726

 Diabetes mellitus

2 (22.2)

1 (7.1)

1 (9.1)

0.519

 Hyperlipidemia

0

1 (7.1)

0

0.479

 Premorbid stroke

2 (22.2)

1 (7.1)

1 (9.1)

0.519

Left hemispheric affected, n (%)

4 (44.4)

5 (35.7)

5 (45.5)

0.863

Infarcted area, n (%)

 2/3 MCA

1 (11.1)

4 (28.6)

5 (45.5)

0.139

 MCA

4 (44.4)

5 (35.7)

6 (54.5)

 

  > MCA

4 (44.4)

5 (35.7)

0

 

GCS, mean ± SD

8.78 ± 2.73

10.71 ± 2.59

10.55 ± 2.54

0.198

NIHSS, mean ± SD

19.78 ± 2.64

17.64 ± 3.69

18.36 ± 3.01

0.337

APACHE II, mean ± SD

14.00 ± 4.18

10.43 ± 3.72

10.82 ± 4.73

0.163

Transtentorial herniation, n (%)

2 (22.2)

3 (21.4)

2 (18.2)

0.971

Prior T/A/A/D, n (%)

4 (44.4)

7 (50.0)

4 (36.4)

0.792

Interval time to DCa, hour, mean ± SD

23.28 ± 15.60

37.32 ± 12.21

30.05 ± 12.65

0.075

  1. MCA middle cerebral artery, GCS glasgow coma scale, NIHSS National Institute of Health Stroke Scale, APACHE II acute physiology and chronic health evaluation II, T/A/A/D treatment with thrombolysis, antiplatelet, anticoagulant or defibrinogen, DC decompressive craniectomy
  2. aInterval from symptom onset to DC: DC group vs. DCSC group, P = 0.025; DC group vs. DCEH group, P = 0.298; DCSC group vs. DCEH group, P = 0.159